Applied Materials reported fiscal fourth-quarter earnings that missed analysts’ expectations, sending shares lower after the ...
Michael Burry, the hedge fund manager famous for his 2008 bet against the US housing market, further increased his exposures ...
The prospect of another US-China trade war on Donald Trump’s return to the White House is largely viewed through the prism of ...
Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug from China's LaNova Medicines.Please watch the video at Investors.com - ...